Association between polymorphisms in the genes for tumor suppressor protein p53 and its regulator NAD(P)H: quinone oxidoreductase 1 (NQO1) and schizophrenia in a Syrian study cohort.

doi:10.1016/j.arcmed.2012.12.009

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Association between polymorphisms in the genes for tumor suppressor protein p53 and its regulator NAD(P)H: quinone oxidoreductase 1 (NQO1) and schizophrenia in a Syrian study cohort.

Archives of medical research - 1 Feb 2013

Lajin Bassam, Alachkar Amal, Michati Roula, Alhaj Sakur Amir

Abstract excerpt

BACKGROUND AND AIMS: The contribution of genetic factors to the susceptibility for developing schizophrenia is well established. Several hypotheses have been developed in an attempt to identify the pathophysiological mechanisms in schizophrenia, with several findings implicating an important role...

Topics

Adult
Cohort Studies
Female
Genes, p53
Genetic Predisposition to Disease
Humans
Male
Middle Aged
NAD(P)H Dehydrogenase (Quinone)
Polymerase Chain Reaction
Polymorphism, Genetic
Schizophrenia
Syria
Tumor Suppressor Protein p53

Source

Open in PubMed

Identifiers

PMID: 23360829
DOI: 10.1016/j.arcmed.2012.12.009

Genes

NQO1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-23360829-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics